Systematic review, meta-analysis and economic modelling of ...

DOI: 10.3310/hta17010 Health Technology Assessment 2013 Vol. 17 No. 1Probability of cost-effectiveness using Mills data 155Lambda (λ), £ Prob NoT Prob ETT Prob HF Prob CTCA Prob CA0 1 0 0 0 01000 1 0 0 0 02000 1 0 0 0 03000 1 0 0 0 04000 1 0 0 0 05000 1 0 0 0 06000 0.9864 0 0.0136 0 07000 0.8634 0 0.1349 0.0017 08000 0.6044 0 0.3672 0.0284 09000 0.3331 0.0001 0.5309 0.1359 010,000 0.1566 0.0009 0.5269 0.3156 011,000 0.0588 0.0012 0.4184 0.5216 012,000 0.0167 0.0010 0.2849 0.6974 013,000 0.0027 0.0012 0.1722 0.8239 014,000 0.0002 0.0005 0.0939 0.9054 015,000 0 0.0001 0.0442 0.9557 016,000 0 0.0001 0.0187 0.9812 017,000 0 0.0003 0.0073 0.9924 018,000 0 0 0.0029 0.9971 019,000 0 0 0.0010 0.9990 020,000 0 0 0.0002 0.9998 021,000 0 0 0 1 0Prob CA, probability that invasive coronary angiography is cost-effective; Prob CTCA, probability that CT coronaryangiography is cost-effective; Prob ETT, probability that exercise tolerance testing is cost-effective; Prob HF, probabilitythat H-FABP is cost-effective; Prob NoT, probability that no testing or treatment is cost-effective.© Queen’s Printer and Controller of HMSO 2013. This work was produced by Goodacre et al. under the terms of a commissioning contract issued by the Secretary of Statefor Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journalsprovided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should beaddressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton SciencePark, Southampton SO16 7NS, UK.175